We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

In this section

Shares

AIM bulletins from ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Physiomics reports strong operational progress

Fri 26 June 2026 16:19

(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its history.

Physiomics reports strong operational progress

Fri 26 June 2026 16:19

(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its history.

Arc Minerals posts wider full-year loss

Fri 26 June 2026 13:11

(Sharecast News) - Arc Minerals reported a wider full-year loss on Friday as it continued to advance copper exploration assets in Botswana and Zambia.

Deltic Energy reports narrower loss ahead of its takeover

Fri 26 June 2026 13:04

(Sharecast News) - Deltic Energy reported a narrower full-year loss on Friday, as shareholders backed its proposed takeover by Neo Next+.

Zephyr Energy acquires another 27,000 acres in Utah

Fri 26 June 2026 12:46

(Sharecast News) - Zephyr Energy said on Friday that it had acquired a further 27,000 acres of federal and state leases in Utah, doubling its acreage footprint around the White Sands Unit at its operated Paradox Basin project.

Crism losses widen as it spends on clinical development

Fri 26 June 2026 12:43

(Sharecast News) - Crism Therapeutics reported a wider full-year loss on Friday, reflecting increased investment in clinical and pre-clinical development as it prepared to start a Phase 2 trial of irinotecan-ChemoSeed in glioblastoma.

Crism losses widen as it spends on clinical development

Fri 26 June 2026 12:43

(Sharecast News) - Crism Therapeutics reported a wider full-year loss on Friday, reflecting increased investment in clinical and pre-clinical development as it prepared to start a Phase 2 trial of irinotecan-ChemoSeed in glioblastoma.

Ampeak shares slide as full-year earnings fall

Fri 26 June 2026 12:37

(Sharecast News) - Ampeak Energy shares fell more than 10% on Friday after the sustainable energy developer reported a sharp drop in EBITDA and a reduction in net assets, despite narrowing its full-year loss and delivering progress across its battery stor

Thruvision posts narrower full-year loss

Fri 26 June 2026 12:22

(Sharecast News) - Thruvision reported a narrower full-year loss on Friday as revenue rose 45%, supported by two large orders in Asia, although margins were hit by discounting of legacy equipment.

Distribution Finance flags higher full-year profit

Fri 26 June 2026 12:02

(Sharecast News) - Distribution Finance Capital said on Friday that full-year profit was expected to be materially ahead of market expectations, after stronger-than-expected lending growth and low impairments in the first half.